Unlike many peptides administered subcutaneously, the primary rationale for IGF-1 DES administration is intramuscular delivery into the target muscle, reflecting its localized mechanism of action
However, a brand-new pilot program starting in July 2026 is completely rewriting these rules for beneficiaries with obesity
It is a synthetic peptide based on a compound found in gastric juice and is often discussed for tissue repair, tendon and ligament support, gut support, and inflammation-related recovery
Consistent with previous research, SES also emerged as a key variable, with individuals in medium-SES regions showing an elevated risk than those in high-SES areas
PlexusDx serves all 50 states without insurance requirements or membership fees, making semaglutide accessible regardless of your coverage status